A shadow economy for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Experimental Drug Gaining Traction Via Social Media
The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are encouraged to contact these accounts directly for supplier links, while also receiving discount codes.
Active Trade on Social Networks
Separately, a robust market exists on messaging services, where communities with numerous of members share comparison photos, administration instructions and assertions of rapid UK delivery. Sellers promote the drug there before redirecting buyers to other platforms for transactions.
Learning About The Experimental Drug
This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.
Healthcare Experts Express Concerns
However, physicians and pharmacists have cautions that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could result in users injecting substances of unknown origin.
Some experts stated the demand for retatrutide could be connected to the rising price of licensed slimming treatments such as Mounjaro.
Regulatory Position and Enforcement
Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations.
Some influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still breach medicines, advertising, and customer laws, potentially leading to fines, legal action or prison.
Service Reaction and Content Removal
Based on TikTok, the service has removed violative content and prohibited related keywords and search suggestions. The organization stated it was committed to maintaining the service secure and allocating resources in strengthening enforcement strategies.
Digital Marketplace Operations
Investigations also discovered groups with up to nine thousand participants selling the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays channels with thousands of users, populated with photos of weight loss, positive reviews and detailed guides for mixing or injecting at home.
After moments of joining one group, a vendor shared WhatsApp details, where most transactions occur. The seller provided an guidebook and promised shipping within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about weight, health issues or past usage.
Product Information and Costs
Within these groups, posts display dark colored parcels with Royal Mail labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with sterile water, or pre-filled pens typically sold at £160 for 20mg. When asked how long a injector should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.
Platform Moderation and Security Actions
A representative for the messaging service said it regularly moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting substances they can’t verify. Even if the science behind this drug is valid, these online products may not include what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are using social media. But fake treatments are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her staff has already seen individuals injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company investigational product not yet authorized … may subject patients to potentially significant health risks”.
